MedPath

Effects of Recurrent PE on Women and Offspring

Not yet recruiting
Conditions
Recurrence
Hypertension
Preeclampsia
Interventions
Other: blood pressure,BMI, blood sample
Registration Number
NCT05134285
Lead Sponsor
Dunjin Chen
Brief Summary

The purpose of this study is to evaluate the risk factors of recurrent preeclampsia and compare the short-term and long-term adverse outcomes of women and their offspring.

Detailed Description

The investigators collected women delivered twice in a row in our hospital. The investigators divided these pregnant women into three groups. Women in the first group did not complicate preeclampsia at both deliveries; Women in the second group complicated preeclampsia at the first delivery or at the second delivery; women in the third group complicated preeclampsia at two deliveries. The investigators explore the risk factors of recurrent preeclampsia and measure blood pressure, blood lipids, thyroid function, glycosylated hemoglobin, ALT, AST, et al. in one year, three years, and five years after the second delivery.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
1000
Inclusion Criteria
  • women with at least twice of delivery history
Exclusion Criteria
  • women with chronic hypertension

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
controlblood pressure,BMI, blood samplepregnancy without preeclampsia
recurrent preeclampsiablood pressure,BMI, blood samplepregnancy complicated with preeclampsia at two deliveries
preeclampsiablood pressure,BMI, blood samplepregnancy complicated with preeclampsia at the first delivery or at the second delivery
Primary Outcome Measures
NameTimeMethod
level of FT3,FT4, and hTSH in blood5 years after the second deliver

women

blood pressure and hypertension of women5 years after the second deliver

blood pressure ≥140/90 mmHg

blood pressure and hypertension of offspring5 years old

blood pressure≥140/90 mmHg

level of cholesterol, LDL, HDL, VLDL-C in blood5 years after the second deliver

women

level of glycosylated hemoglobin in blood5 years after the second deliver

women

level of AST and ALT in blood5 years after the second deliver

women

Secondary Outcome Measures
NameTimeMethod
BMI of offspring5 years old

weight(kg)/height(m)2

level of AI37℃、AI4℃、PRA、ALD、AngII in blood5 years after the second deliver

women

level of fructosamine in blood5 years after the second deliver

women

level of insulin in blood5 years after the second deliver

women

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University

🇨🇳

Guangzhou, China

© Copyright 2025. All Rights Reserved by MedPath